Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antengene, Aquavit, Arrowhead, Aviceda, Boan, Diamond, Enlivex, Fore, Ichnos, Intellia, Jiangsu Recbio, Luye, Mereo, Prestige, Sanofi, Sensei.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alexion, Astrazeneca, Beigene, Devshealth, Disc Enveric, Evofem, Ingenū, Lucy Scientific, Psyence, Quralis, Wesana, Zura.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allarity, Clairvoyant, Enlivex, Genentech, Kangpu, Karuna, Newron, Orsobio, Pharvaris, Rayzebio, Vaccitech, Vaxxinity, Xalud.

Biopharmas raising money in public or private financings, including: Algernon, Avicann, Karuna, Oxurion, Scilex.

New hires and promotions in the biopharma industry, including: Akoya, Ankyra, Apie, Beam, Cytovation, Decibel, Gamida Cell, Nextpoint, Sonata, Wugen.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affamed, Asensus Surgical, Cue Health, Lunit, Surgvision.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Brain Scientific, Detection Technology, Genetworx, Imac Holdings, Oxford Nanopore, Northern Light, Quest Diagnostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Dermasensor.

New hires and promotions in the med-tech industry, including: Boston Imaging, Inspiremd.